Skip to main content

Table 1 Clinical characteristics of 117 cases with hyperthyroidism

From: Thyroid function and non-alcoholic fatty liver disease in hyperthyroidism patients

Characteristics Total
(n = 117)
Without NAFLD
(n = 103)
With NAFLD
(n = 14)
P-value
Age (years) 45.35 ± 12.78 44.72 ± 13.04 50.00 ± 9.88 0.148
Gender(M/F) 34/83 29/74 5/9 0.559
BMI (kg/m2) 22.55 ± 3.38 22.19 ± 3.31 25.23 ± 2.72 0.001
Waist circumference (cm) 80.82 ± 9.52 79.93 ± 9.19 90.29 ± 8.06 0.005
SBP (mmHg) 122.52 ± 13.79 121.82 ± 13.77 127.71 ± 13.33 0.115
DBP (mmHg) 74.32 ± 9.35 73.73 ± 9.34 78.71 ± 8.50 0.115
FBG (mmol/L) 5.09 ± 1.08 5.04 ± 0.91 5.48 ± 1.92 0.159
f-INS (mU/L) 8.70(6.50,10.60) 8.70(6.20,10.55) 8.90 (7.35,11.63) 0.690
TG (mmol/L) 0.99 ± 0.49 0.94 ± 0.43 1.36 ± 0.71 0.048
TC (mmol/L) 3.45 ± 0.81 3.37 ± 0.76 4.00 ± 0.95 0.006
LDL (mmol/L) 1.79 ± 0.66 1.72 ± 0.62 2.26 ± 0.76 0.004
IL6(pg/ml) 2.30 (2.00,3.00) 2.30 (2.00,3.00) 2.10 (2.00,3.00) 0.564
HCRP (mg/L) 0.80 (0.40,1.98) 0.80 (0.40,2.05) 0.90 (0.70,1.70) 0.594
UA (umol/L) 292.89 ± 69.51 293.14 ± 66.50 291.07 ± 91.53 0.917
ALT(U/L) 36.80 ± 33.06 38.32 ± 34.45 25.64 ± 16.96 0.179
AST(U/L) 27.15 ± 16.61 27.86 ± 17.10 21.86 ± 11.50 0.206
FT3(pmol/L) 20.42 ± 12.73 21.69 ± 12.57 11.09 ± 10.01 0.002
FT4(pmol/L) 54.15 ± 29.87 57.11 ± 29.58 32.41 ± 22.73 0.002
TSH (uIU/ml) 0.005 (0.005, 0.010) 0.005 (0.005, 0.010) 0.005 (0.005, 0.508) 0.824
HOMA-IR 1.90 (1.38,2.54) 1.86 (1.37,2.52) 2.26 (1.56,3.22) 0.956
  1. BMI Body-mass-index, SBP Systolic Blood Pressure, DBP Diastolic blood pressure, FBG Fasting blood glucose, f-INS Fasting insulin, TG Triglyceride, TC Serum total cholesterol, LDL Low density lipoprotein, IL-6 Interleukin-6, HCRBP Hypersensitive C-reactive protein, UA Uric acid, ALT Alanine aminotransferase, AST Aspartate aminotransferase, FT3 Free triiodothyronine, FT4 Free thyroxine, TSH Thyroid-stimulating hormone, HOMA-IR Homeostasis model assessment for insulin resistance